InMed Pharmaceuticals Submits Clinical Trial Applications to Evaluate INM-755 (Cannabinol) Cream in a Phase 2 Trial for Epidermolysis Bullosa
April 28, 2021 07:30 ET
|
InMed Pharmaceuticals Inc.
Filings submitted in Austria, Israel, and Serbia for a Phase 2 Clinical Trial with INM-755 creamAdditional submissions slated for France, Germany, Greece, and Italy over the next several days and...
InMed Pharmaceuticals Announces Voluntary Delisting from TSX
April 27, 2021 07:30 ET
|
InMed Pharmaceuticals Inc.
VANCOUVER, British Columbia, April 27, 2021 (GLOBE NEWSWIRE) -- InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq:INM) (TSX:IN), a clinical-stage company developing cannabinoid-based...
InMed Pharmaceuticals Achieves 2g/L Cannabinoid Yield with IntegraSyn™
April 26, 2021 07:30 ET
|
InMed Pharmaceuticals Inc.
VANCOUVER, British Columbia, April 26, 2021 (GLOBE NEWSWIRE) -- InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM; TSX:IN), a clinical-stage company developing cannabinoid-based...
InMed to Present at Virtual Conferences in March 2021
March 03, 2021 18:00 ET
|
InMed Pharmaceuticals Inc.
VANCOUVER, British Columbia, March 03, 2021 (GLOBE NEWSWIRE) -- InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM; TSX:IN), a clinical-stage company developing cannabinoid-based...
InMed Pharmaceuticals announces increase in Bought Deal offering to $13 million
June 12, 2018 09:54 ET
|
InMed Pharmaceuticals Inc.
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, June 12, 2018 (GLOBE NEWSWIRE) -- InMed Pharmaceuticals Inc. (TSX:IN)...
InMed Pharmaceuticals Announces $10 Million Bought Deal
June 12, 2018 07:30 ET
|
InMed Pharmaceuticals Inc.
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, B.C., June 12, 2018 (GLOBE NEWSWIRE) -- InMed Pharmaceuticals Inc. (TSX:IN) (“InMed”...
InMed Pharmaceuticals Announces Marketed Offering of Common Shares
April 21, 2017 05:30 ET
|
InMed Pharmaceuticals, Inc.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - April 21, 2017) -
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
InMed...
InMed Announces Appointment of Eric A. Adams as CEO, President and Director
June 16, 2016 09:02 ET
|
InMed Pharmaceuticals Inc.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - June 16, 2016) - InMed Pharmaceuticals Inc. ("InMed" or "the Company") (CSE:IN)(OTCQB:IMLFF), a biopharmaceutical company specializing...
InMed Announces Update on Biosynthesis Project
February 16, 2016 06:00 ET
|
InMed Pharmaceuticals Inc.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Feb. 16, 2016) - InMed Pharmaceuticals Inc. ("InMed" or "the Company") (CSE:IN)(OTCQB:IMLFF), a biopharmaceutical company...
InMed Strengthens Board With Appointment of Experienced Biotech Executive Adam Cutler
November 23, 2015 06:00 ET
|
InMed Pharmaceuticals Inc.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Nov. 23, 2015) - InMed Pharmaceuticals Inc. ("InMed") (CSE:IN)(OTCQB:IMLFF), a biopharmaceutical company specializing in the research and...